✦ LIBER ✦

Gossypol Treatment of Recurrent Adult Malignant Gliomas

✍ Scribed by Peter Bushunow; Marcus M. Reidenberg; John Wasenko; Jeffrey Winfield; Beverly Lorenzo; Sheila Lemke; Benjamin Himpler; Robert Corona; Thomas Coyle

Book ID: 110233703
Publisher: Springer US
Year: 1999
Tongue: English
Weight: 96 KB
Volume: 43
Category: Article
ISSN: 0167-594X
DOI: 10.1023/a:1006267902186

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Recurrent malignant glioma in adults

✍ Stephen B. Tatter 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 514 KB

Treatment of recurrent malignant suprate

Treatment of recurrent malignant supratentorial gliomas with carboplatin (CBDCA)

✍ M. Poisson; Y. Péréon; J. Chiras; J. Y. Delattre 📂 Article 📅 1991 🏛 Springer US 🌐 English ⚖ 363 KB

Twenty patients with malignant supratentorial gliomas progressing after radiation therapy and chemotherapy with nitrosoureas received intravenous carboplatin, 450 mg/m 2. Courses of therapy were repeated every four weeks. Therapeutic evaluation was performed monthly using neurologic examination and

A comparison of treatment results for re

A comparison of treatment results for recurrent malignant gliomas

✍ C. Nieder; A.L. Grosu; M. Molls 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Patterns of recurrence following treatme

Patterns of recurrence following treatment for malignant glioma

✍ Branislav Jeremic; Danica Grujicic; Ljubodrag Djuric; Ljiljana Mijatovic; Dobril 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 97 KB

Temozolomide in the treatment of recurre

Temozolomide in the treatment of recurrent malignant glioma

✍ Susan M. Chang; Philip Theodosopoulos; Kathleen Lamborn; Mary Malec; Jane Rabbit 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 1 views

## Abstract ## BACKGROUND Options for chemotherapy at the time of recurrence in patients with malignant glioma are limited. The authors describe the efficacy and safety results of their institution's open‐label, compassionate‐use protocol of temozolomide for patients with recurrent malignant gliom

Topotecan treatment of adults with prima

Topotecan treatment of adults with primary malignant glioma

✍ Henry S. Friedman; Tracy Kerby; Scott Fields; Janice E. Zilisch; David Graden; R 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 255 KB 👁 1 views

## BACKGROUND. Topotecan activity was evaluated for the treatment of malignant glioma. ## METHODS. Sixty-three patients with newly diagnosed (n ϭ 25) or recurrent (n ϭ 38) malignant glioma were treated with topotecan {AU: Please verify all dosages here and throughout text.}at a dose of 2.6 mg/m